AAAAAA

   
Results: 1-25 | 26-37
Results: 1-25/37
PROGNOSTIC-SIGNIFICANCE OF AGE, MYCN ONCOGENE AMPLIFICATION, TUMOR-CELL PLOIDY, AND HISTOLOGY IN 110 INFANTS WITH STAGE D(S) NEUROBLASTOMA - THE PEDIATRIC-ONCOLOGY-GROUP EXPERIENCE - A PEDIATRIC-ONCOLOGY-GROUPSTUDY
Authors: KATZENSTEIN HM BOWMAN LC BRODEUR GM THORNER PS JOSHI VV SMITH EI LOOK AT ROWE ST NASH MB HOLBROOK T ALVARADO C RAO PV CASTLEBERRY RP COHN SL
Citation: Hm. Katzenstein et al., PROGNOSTIC-SIGNIFICANCE OF AGE, MYCN ONCOGENE AMPLIFICATION, TUMOR-CELL PLOIDY, AND HISTOLOGY IN 110 INFANTS WITH STAGE D(S) NEUROBLASTOMA - THE PEDIATRIC-ONCOLOGY-GROUP EXPERIENCE - A PEDIATRIC-ONCOLOGY-GROUPSTUDY, Journal of clinical oncology, 16(6), 1998, pp. 2007-2017
THE RISK OF NEPHRECTOMY DURING LOCAL-CONTROL IN ABDOMINAL NEUROBLASTOMA
Authors: SHAMBERGER RC SMITH EI JOSHI VV RAO PV HAYES FA BOWMAN LC CASTLEBERRY RP
Citation: Rc. Shamberger et al., THE RISK OF NEPHRECTOMY DURING LOCAL-CONTROL IN ABDOMINAL NEUROBLASTOMA, Journal of pediatric surgery, 33(2), 1998, pp. 161-164
MUTATIONS OF THE NF1 GENE IN CHILDREN WITH JUVENILE MYELOMONOCYTIC LEUKEMIA WITHOUT CLINICAL-EVIDENCE OF NEUROFIBROMATOSIS, TYPE-1
Authors: SIDE LE EMANUEL PD TAYLOR B FRANKLIN J THOMPSON P CASTLEBERRY RP SHANNON KM
Citation: Le. Side et al., MUTATIONS OF THE NF1 GENE IN CHILDREN WITH JUVENILE MYELOMONOCYTIC LEUKEMIA WITHOUT CLINICAL-EVIDENCE OF NEUROFIBROMATOSIS, TYPE-1, Blood, 92(1), 1998, pp. 267-272
PARENTAL RESIDENTIAL PESTICIDE EXPOSURE AND THE RISK OF NEUROBLASTOMA
Authors: DANIELS JD OLSHAN AF TESCHKE T BONDY M SHAH N CASTLEBERRY RP POLLOCK BH
Citation: Jd. Daniels et al., PARENTAL RESIDENTIAL PESTICIDE EXPOSURE AND THE RISK OF NEUROBLASTOMA, American journal of epidemiology, 147(11), 1998, pp. 175-175
PARENTAL OCCUPATION AND THE RISK OF NEUROBLASTOMA IN OFFSPRING - A CASE-CONTROL STUDY
Authors: DEROOS AJ OLSHAN AF TESCHKE K NEGLIA JP STRAM DO CASTLEBERRY RP POLLOCK BH
Citation: Aj. Deroos et al., PARENTAL OCCUPATION AND THE RISK OF NEUROBLASTOMA IN OFFSPRING - A CASE-CONTROL STUDY, American journal of epidemiology, 147(11), 1998, pp. 341-341
GENETIC STAGING OF UNRESECTABLE OR METASTATIC NEUROBLASTOMA IN INFANTS - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: BOWMAN LC CASTLEBERRY RP CANTOR A JOSHI V COHN SL SMITH EI YU A BRODEUR GM HAYES FA LOOK AT
Citation: Lc. Bowman et al., GENETIC STAGING OF UNRESECTABLE OR METASTATIC NEUROBLASTOMA IN INFANTS - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Journal of the National Cancer Institute, 89(5), 1997, pp. 373-380
CHEMOTHERAPY FOR PATIENTS WITH RECURRENT OR REFRACTORY NEUROBLASTOMA - A POG PHASE-II STUDY
Authors: ALVARADO CS KRETSCHMAR C JOSHI VV TOLEDANO S CANTOR A STROTHER D NITSCHKE R CASTLEBERRY RP
Citation: Cs. Alvarado et al., CHEMOTHERAPY FOR PATIENTS WITH RECURRENT OR REFRACTORY NEUROBLASTOMA - A POG PHASE-II STUDY, Journal of pediatric hematology/oncology, 19(1), 1997, pp. 62-67
NEUROBLASTOMA
Authors: CASTLEBERRY RP
Citation: Rp. Castleberry, NEUROBLASTOMA, European journal of cancer, 33(9), 1997, pp. 1430-1437
THE INTERNATIONAL NEUROBLASTOMA RISK GROUPS (INRG) - A PRELIMINARY-REPORT
Authors: CASTLEBERRY RP PRITCHARD J AMBROS P BERTHOLD F BRODEUR GM CASTEL V COHN SL DEBERNARDI B DICKSMIREAUX C FRAPPAZ D HAASE GM HABER M JONES DR JOSHI VV KANEKO M KEMSHEAD JT KOGNER P LEE REJ MATTHAY KK MICHON JM MONCLAIR R ROALD BR SEEGER RC SHAW PJ SHIMADA H SHUSTER JJ
Citation: Rp. Castleberry et al., THE INTERNATIONAL NEUROBLASTOMA RISK GROUPS (INRG) - A PRELIMINARY-REPORT, European journal of cancer, 33(12), 1997, pp. 2113-2116
EVENT-FREE SURVIVAL OF CHILDREN WITH BIOLOGICALLY FAVORABLE NEUROBLASTOMA BASED ON THE DEGREE OF INITIAL TUMOR RESECTION - RESULTS FROM THEPEDIATRIC-ONCOLOGY-GROUP
Authors: STROTHER D VANHOFF J RAO PV SMITH EI SHAMBERGER RC HALPERIN EC MURRAY KJ CASTLEBERRY RP
Citation: D. Strother et al., EVENT-FREE SURVIVAL OF CHILDREN WITH BIOLOGICALLY FAVORABLE NEUROBLASTOMA BASED ON THE DEGREE OF INITIAL TUMOR RESECTION - RESULTS FROM THEPEDIATRIC-ONCOLOGY-GROUP, European journal of cancer, 33(12), 1997, pp. 2121-2125
BIOLOGY AND TREATMENT OF NEUROBLASTOMA
Authors: CASTLEBERRY RP
Citation: Rp. Castleberry, BIOLOGY AND TREATMENT OF NEUROBLASTOMA, The Pediatric clinics of North America, 44(4), 1997, pp. 919
A PHASE-II STUDY OF 13-CIS RETINOIC ACID (CRA) IN JUVENILE MYELOMONOCYTIC LEUKEMIA (JMML) - A PEDIATRIC-ONCOLOGY-GROUP (POG) STUDY
Authors: CASTLEBERRY RP CHANG M MAYBEE D EMANUEL PD
Citation: Rp. Castleberry et al., A PHASE-II STUDY OF 13-CIS RETINOIC ACID (CRA) IN JUVENILE MYELOMONOCYTIC LEUKEMIA (JMML) - A PEDIATRIC-ONCOLOGY-GROUP (POG) STUDY, Blood, 90(10), 1997, pp. 1543-1543
MAINTENANCE OF CLONALITY IN LONG-TERM CULTURES OF JUVENILE MYELOMONOCYTIC LEUKEMIA-CELLS
Authors: EMANUEL PD LIU Y CASTLEBERRY RP PRCHAL JT
Citation: Pd. Emanuel et al., MAINTENANCE OF CLONALITY IN LONG-TERM CULTURES OF JUVENILE MYELOMONOCYTIC LEUKEMIA-CELLS, Blood, 90(10), 1997, pp. 1550-1550
INCREASED LEVELS OF THE P85-ALPHA REGULATORY SUBUNIT OF PHOSPHATIDYLINOSITOL 3-OH KINASE IN CELL LYSATES OF JUVENILE MYELOMONOCYTIC LEUKEMIA-CELLS
Authors: SNYDER RC WILEY T CASTLEBERRY RP EMANUEL PD
Citation: Rc. Snyder et al., INCREASED LEVELS OF THE P85-ALPHA REGULATORY SUBUNIT OF PHOSPHATIDYLINOSITOL 3-OH KINASE IN CELL LYSATES OF JUVENILE MYELOMONOCYTIC LEUKEMIA-CELLS, Blood, 90(10), 1997, pp. 1829-1829
GROWTH-INHIBITORY EFFECTS OF A PROTEIN FARNESYLTRANSFERASE INHIBITOR IN JUVENILE MYELOMONOCYTIC LEUKEMIA
Authors: EMANUEL PD SOKOL JM SYNDER RC OLIFF A CASTLEBERRY RP
Citation: Pd. Emanuel et al., GROWTH-INHIBITORY EFFECTS OF A PROTEIN FARNESYLTRANSFERASE INHIBITOR IN JUVENILE MYELOMONOCYTIC LEUKEMIA, Blood, 90(10), 1997, pp. 2522-2522
JUVENILE MYELOMONOCYTIC LEUKEMIA - MOLECULAR UNDERSTANDING AND PROSPECTS FOR THERAPY
Authors: EMANUEL PD SHANNON KM CASTLEBERRY RP
Citation: Pd. Emanuel et al., JUVENILE MYELOMONOCYTIC LEUKEMIA - MOLECULAR UNDERSTANDING AND PROSPECTS FOR THERAPY, Molecular medicine today, 2(11), 1996, pp. 468-475
MODIFIED HISTOLOGIC GRADING OF NEUROBLASTOMAS BY REPLACEMENT OF MITOTIC RATE WITH MITOSIS KARYORRHEXIS INDEX - A CLINICOPATHOLOGICAL STUDY OF 223 CASES FROM THE PEDIATRIC-ONCOLOGY-GROUP
Authors: JOSHI VV RAO PV CANTOR AB ALTSHULER G SHUSTER JJ CASTLEBERRY RP
Citation: Vv. Joshi et al., MODIFIED HISTOLOGIC GRADING OF NEUROBLASTOMAS BY REPLACEMENT OF MITOTIC RATE WITH MITOSIS KARYORRHEXIS INDEX - A CLINICOPATHOLOGICAL STUDY OF 223 CASES FROM THE PEDIATRIC-ONCOLOGY-GROUP, Cancer, 77(8), 1996, pp. 1582-1588
CONVENTIONAL VERSUS MODIFIED MORPHOLOGIC CRITERIA FOR GANGLIONEUROBLASTOMA - A REVIEW OF CASES FROM THE PEDIATRIC-ONCOLOGY-GROUP
Authors: JOSHI VV CANTOR AB ALTSHULER G COHEN LJ LARKIN EW SHUSTER JJ RAO PV HOLBROOK CT HAYES FA CASTLEBERRY RP
Citation: Vv. Joshi et al., CONVENTIONAL VERSUS MODIFIED MORPHOLOGIC CRITERIA FOR GANGLIONEUROBLASTOMA - A REVIEW OF CASES FROM THE PEDIATRIC-ONCOLOGY-GROUP, Archives of pathology and laboratory medicine, 120(9), 1996, pp. 859-865
STAGE-SPECIFIC EXPRESSION OF INTEGRIN ALPHA-V-BETA-3 IN NEUROBLASTIC TUMORS
Authors: GLADSON CL HANCOCK S ARNOLD MM FAYEPETERSEN OM CASTLEBERRY RP KELLY DR
Citation: Cl. Gladson et al., STAGE-SPECIFIC EXPRESSION OF INTEGRIN ALPHA-V-BETA-3 IN NEUROBLASTIC TUMORS, The American journal of pathology, 148(5), 1996, pp. 1423-1434
JUVENILE CHRONIC MYELOGENOUS LEUKEMIA
Authors: HESS JL ZUTTER MM CASTLEBERRY RP EMANUEL PD
Citation: Jl. Hess et al., JUVENILE CHRONIC MYELOGENOUS LEUKEMIA, American journal of clinical pathology, 105(2), 1996, pp. 238-248
PHASE-II WINDOW THERAPY - REPLY
Authors: CASTLEBERRY RP
Citation: Rp. Castleberry, PHASE-II WINDOW THERAPY - REPLY, Journal of clinical oncology, 13(1), 1995, pp. 302-303
CYCLOPHOSPHAMIDE DOXORUBICIN VS CISPLATIN TENIPOSIDE IN THE TREATMENTOF CHILDREN OLDER THAN 12 MONTHS OF AGE WITH DISSEMINATED NEUROBLASTOMA - A PEDIATRIC-ONCOLOGY-GROUP RANDOMIZED PHASE-II STUDY
Authors: MCWILLIAMS NB HAYES FA GREEN AA SMITH EI NITSCHKE R ALTSHULER GA SHUSTER JJ CASTLEBERRY RP VIETTI TJ
Citation: Nb. Mcwilliams et al., CYCLOPHOSPHAMIDE DOXORUBICIN VS CISPLATIN TENIPOSIDE IN THE TREATMENTOF CHILDREN OLDER THAN 12 MONTHS OF AGE WITH DISSEMINATED NEUROBLASTOMA - A PEDIATRIC-ONCOLOGY-GROUP RANDOMIZED PHASE-II STUDY, Medical and pediatric oncology, 24(3), 1995, pp. 176-180
ISOTRETINOIN FOR JUVENILE CHRONIC MYELOGENOUS LEUKEMIA - REPLY
Authors: CASTLEBERRY RP EMANUEL PD
Citation: Rp. Castleberry et Pd. Emanuel, ISOTRETINOIN FOR JUVENILE CHRONIC MYELOGENOUS LEUKEMIA - REPLY, The New England journal of medicine, 332(22), 1995, pp. 1521-1521
BIOLOGICAL VARIABLES IN THORACIC NEUROBLASTOMA - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: MORRIS JA SHOCHAT SJ SMITH EI LOOK AT BRODEUR GM CANTOR AB CASTLEBERRY RP
Citation: Ja. Morris et al., BIOLOGICAL VARIABLES IN THORACIC NEUROBLASTOMA - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Journal of pediatric surgery, 30(2), 1995, pp. 296-303
LACK OF CORRELATION OF N-MYC GENE AMPLIFICATION WITH PROGNOSIS IN LOCALIZED NEUROBLASTOMA - A PEDIATRIC-ONCOLOGY-GROUP STUDY
Authors: COHN SL LOOK AT JOSHI VV HOLBROOK T SALWEN H CHAGNOVICH D CHESLER L ROWE ST VALENTINE MB KOMURO H CASTLEBERRY RP BOWMAN LC RAO PV SEEGER RC BRODEUR GM
Citation: Sl. Cohn et al., LACK OF CORRELATION OF N-MYC GENE AMPLIFICATION WITH PROGNOSIS IN LOCALIZED NEUROBLASTOMA - A PEDIATRIC-ONCOLOGY-GROUP STUDY, Cancer research, 55(4), 1995, pp. 721-726
Risultati: 1-25 | 26-37